Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells

ST elevation myocardial infarction (STEMI) is associated with an increased risk for congestive heart failure and long-term mortality despite the widespread use of thrombolysis and catheter-based revascularization. The need for improved post-STEMI therapies has led to a surge of novel therapeutics, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Poole, Joseph C., Quyyumi, Arshed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655659/
https://www.ncbi.nlm.nih.gov/pubmed/23737803
http://dx.doi.org/10.1155/2013/658480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655659/
https://www.ncbi.nlm.nih.gov/pubmed/23737803
http://dx.doi.org/10.1155/2013/658480

Ejemplares similares